| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 From the Laser Research Laboratory, Retina Service, Massachusetts Eye and Ear Infirmary, Harvard Medical School; and the 2 Department of Dermatology, Wellman Laboratories of Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Abstract
PURPOSE. To study the long-term effects of photodynamic therapy (PDT), using liposomal benzoporphyrin derivative (BPD) or Verteporfin, on experimental choroidal neovascularization (CNV) and on normal retina and choroid (with no CNV) in the cynomolgus monkey eye.
METHODS. Photodynamic therapy was performed in 8 cynomolgus monkey eyes with experimental CNV induced by laser injury. The effect of PDT on normal retina and choroid (with no CNV) was studied in 9 monkey eyes. Liposomal BPD was administered intravenously (0.375 mg/kg) either as a bolus, as a slow infusion over 32 minutes, or as a fast infusion over 10 minutes. Photodynamic therapy was performed using light at a wavelength of 689 or 692 nm, with an irradiance of 600 mW/cm2 and fluence of 150 J/cm2. Follow-up studies, including fundus photography and FA, were performed at 24 hours after PDT and then weekly. Indocyanine green and BPD angiography were performed in selected cases. Tissues were examined with light and electron microscopy at the end of follow-up.
RESULTS. Twenty-three of the 32 areas of CNV treated with PDT showed absence of angiographic leakage at 24 hours. Twenty-eight areas of CNV were followed for 4 weeks; 22 of 28 showed absence of angiographic leakage at 2 weeks; and 20 of 28 at 4 weeks of follow-up. Forty spots on the normal retina and choroid were treated with PDT and were followed for 4 to 7 weeks. These spots showed pigment-laden cells in the outer retina, variably pigmented retinal pigment epithelium (RPE) in the treated area, intact neurosensory retina, and reperfusion of the choriocapillaris.
CONCLUSIONS. Photodynamic therapy leads to absence of angiographic leakage for at least 4 weeks in experimental CNV in the monkey model. In the normal monkey eye the RPE and choriocapillaris show generalized recovery with preservation of the neurosensory retina 7 weeks after PDT.
This article has been cited by other articles:
|
|
 |
|
  S J Kang, I Schmack, H E Benson, and H E Grossniklaus Histopathological findings in postmortem eyes after photodynamic therapy for choroidal neovascularisation in age-related macular degeneration: report of two cases Br. J. Ophthalmol., December 1, 2007; 91(12): 1602 - 1606. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ishikawa, M. Kondo, Y. Ito, M. Kikuchi, H. Nishihara, C.-H. Piao, T. Sugita, and H. Terasaki Correlation between Focal Macular Electroretinograms and Angiographic Findings after Photodynamic Therapy Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2254 - 2259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Framme, H. G. Sachs, B. Flucke, D. Theisen-Kunde, and R. Birngruber Evaluation of the New Photosensitizer Tookad (WST09) for Photodynamic Vessel Occlusion of the Choroidal Tissue in Rabbits Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5437 - 5446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H Imai, S Honda, Y Nakanishi, H Yamamoto, Y Tsukahara, and A Negi Different transitions of multifocal electroretinogram recordings between patients with age-related macular degeneration and polypoidal choroidal vasculopathy after photodynamic therapy Br. J. Ophthalmol., December 1, 2006; 90(12): 1524 - 1530. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. K. Kim, D. Husain, N. Michaud, E. Connolly, A. M. Lane, K. Durrani, A. Hafezi-Moghadam, E. S. Gragoudas, C. A. O'Neill, J. C. Beyer, et al. Effect of Intravitreal Injection of Ranibizumab in Combination with Verteporfin PDT on Normal Primate Retina and Choroid Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 357 - 363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Michels, F. Hansmann, W. Geitzenauer, and U. Schmidt-Erfurth Influence of Treatment Parameters on Selectivity of Verteporfin Therapy Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 371 - 376. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Tzekov, T. Lin, K.-M. Zhang, B. Jackson, A. Oyejide, W. Orilla, A. D. Kulkarni, B. D. Kuppermann, L. Wheeler, and J. Burke Ocular Changes after Photodynamic Therapy Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 377 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Klais, M. D. Ober, K. B. Freund, L. H. Ginsburg, A. Luckie, M. Mauget-Faysse, G. Coscas, N. E. Gross, and L. A. Yannuzzi Choroidal Infarction Following Photodynamic Therapy With Verteporfin Arch Ophthalmol, August 1, 2005; 123(8): 1149 - 1153. [Full Text] [PDF]
|
|
|
|
|
|
M. H. Criswell, T. A. Ciulla, L. A. Lowseth, W. Small, R. P. Danis, and D. L. Carson Anastomotic Vessels Remain Viable after Photodynamic Therapy in Primate Models of Choroidal Neovascularization Invest. Ophthalmol. Vis. Sci., June 1, 2005; 46(6): 2168 - 2174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A M Armbrecht, P A Aspinall, and B Dhillon A prospective study of visual function and quality of life following PDT in patients with wet age related macular degeneration Br. J. Ophthalmol., October 1, 2004; 88(10): 1270 - 1273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Slomiany and S. A. Rosenzweig Autocrine effects of IGF-I-induced VEGF and IGFBP-3 secretion in retinal pigment epithelial cell line ARPE-19 Am J Physiol Cell Physiol, September 1, 2004; 287(3): C746 - C753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Slomiany and S. A. Rosenzweig IGF-1-Induced VEGF and IGFBP-3 Secretion Correlates with Increased HIF-1{alpha} Expression and Activity in Retinal Pigment Epithelial Cell Line D407 Invest. Ophthalmol. Vis. Sci., August 1, 2004; 45(8): 2838 - 2847. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Z. Renno, Y. Terada, M. J. Haddadin, N. A. Michaud, E. S. Gragoudas, and J. W. Miller Selective Photodynamic Therapy by Targeted Verteporfin Delivery to Experimental Choroidal Neovascularization Mediated by a Homing Peptide to Vascular Endothelial Growth Factor Receptor-2 Arch Ophthalmol, July 1, 2004; 122(7): 1002 - 1011. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Criswell, T. A. Ciulla, T. E. Hill, W. Small, R. P. Danis, W. J. Snyder, L. A. Lowseth, and D. L. Carson The Squirrel Monkey: Characterization of a New-World Primate Model of Experimental Choroidal Neovascularization and Comparison with the Macaque Invest. Ophthalmol. Vis. Sci., February 1, 2004; 45(2): 625 - 634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W-M Chan, D S C Lam, T Y Y Lai, B S M Tam, D T L Liu, and C K M Chan Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level Br. J. Ophthalmol., December 1, 2003; 87(12): 1453 - 1458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Schmidt-Erfurth, U. Schlotzer-Schrehard, C. Cursiefen, S. Michels, A. Beckendorf, and G. O. H. Naumann Influence of Photodynamic Therapy on Expression of Vascular Endothelial Growth Factor (VEGF), VEGF Receptor 3, and Pigment Epithelium-Derived Factor Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4473 - 4480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Arroyo, N. Michaud, and F. A. Jakobiec Choroidal Neovascular Membranes Treated With Photodynamic Therapy Arch Ophthalmol, June 1, 2003; 121(6): 898 - 903. [Full Text] [PDF]
|
|
|
|
|
|
D. N. Zacks, E. Ezra, Y. Terada, N. Michaud, E. Connolly, E. S. Gragoudas, and J. W. Miller Verteporfin Photodynamic Therapy in the Rat Model of Choroidal Neovascularization: Angiographic and Histologic Characterization Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2384 - 2391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Schmidt-Erfurth, H. Laqua, U. Schlotzer-Schrehard, A. Viestenz, and G. O. H. Naumann Histopathological Changes Following Photodynamic Therapy in Human Eyes Arch Ophthalmol, June 1, 2002; 120(6): 835 - 844. [Full Text] [PDF]
|
|
|
|
|
|
U. Schmidt-Erfurth, S. Michels, I. Barbazetto, and H. Laqua Photodynamic Effects on Choroidal Neovascularization and Physiological Choroid Invest. Ophthalmol. Vis. Sci., March 1, 2002; 43(3): 830 - 841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Krzystolik, M. A. Afshari, A. P. Adamis, J. Gaudreault, E. S. Gragoudas, N. A. Michaud, W. Li, E. Connolly, C. A. O'Neill, and J. W. Miller Prevention of Experimental Choroidal Neovascularization With Intravitreal Anti-Vascular Endothelial Growth Factor Antibody Fragment Arch Ophthalmol, March 1, 2002; 120(3): 338 - 346. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Obana, Y. Gohto, K. Kaneda, S. Nakajima, and T. Miki PDT to Monkey CNV with ATX-S10(Na): Inappropriateness of Early Laser Irradiation for Selective Occlusion Invest. Ophthalmol. Vis. Sci., October 1, 2001; 42(11): 2639 - 2645. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. SOUBRANE and N. M BRESSLER Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy Br. J. Ophthalmol., April 1, 2001; 85(4): 483 - 495. [Full Text]
|
|
|
|
|
|
N. Lange, J.-P. Ballini, G. Wagnieres, and H. van den Bergh A New Drug-Screening Procedure for Photosensitizing Agents Used in Photodynamic Therapy for CNV Invest. Ophthalmol. Vis. Sci., January 1, 2001; 42(1): 38 - 46. [Abstract] [Full Text]
|
|
|
|
|
|
R. Z. Renno, F. C. Delori, R. A. Holzer, E. S. Gragoudas, and J. W. Miller Photodynamic Therapy Using Lu-Tex Induces Apoptosis In Vitro, and Its Effect Is Potentiated by Angiostatin in Retinal Capillary Endothelial Cells Invest. Ophthalmol. Vis. Sci., November 1, 2000; 41(12): 3963 - 3971. [Abstract] [Full Text]
|
|
|
|
|
|
M. Sickenberg, U. Schmidt-Erfurth, J. W. Miller, C. J. Pournaras, L. Zografos, B. Piguet, G. Donati, H. Laqua, I. Barbazetto, E. S. Gragoudas, et al. A Preliminary Study of Photodynamic Therapy Using Verteporfin for Choroidal Neovascularization in Pathologic Myopia, Ocular Histoplasmosis Syndrome, Angioid Streaks, and Idiopathic Causes Arch Ophthalmol, March 1, 2000; 118(3): 327 - 336. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
